Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

ACCESSWIRE News Releases

Aug 14, 2019 06:30 ET
Aug 14, 2019 06:00 ET
Cyren Announces Second Quarter 2019 Financial Results
First Half Revenue Up 15% as Quarterly Revenue Increases 6% Year-Over-Year...
Aug 14, 2019 04:30 ET
Valeura Energy Inc Announces Stock option plan block listing application
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com...
Aug 14, 2019 03:30 ET
Ximen Mining Corp’s Option Partner to Drill Treasure Mountain Silver Property Tulameen BC
VANCOUVER, BC / ACCESSWIRE / August 13, 2019 / Ximen Mining Corp. (TSX.v: XIM) (FRA: 1XMA) (OTCQB:XXMMF) (the “Company” or “Ximen”) ”) is pleased to announce its option partner New Destiny Mining Corp. (TSX.v NED) is mobilizing a drill to the Treasure Mountain Silver Property, located near Tulameen, B.C....
Aug 14, 2019 03:10 ET
Casa Deploys Exploration Team, Prepares for 2019 Drilling and Received Drilling Permit for Pitman Project
VANCOUVER, BC / ACCESSWIRE / Aug 14, 2019 / Casa Minerals Inc. (TSX-V:CASA)(OTC:CASXF)(Frankfurt:0CM) (the “Company” or “Casa”) announces that it has received a Mines Act permit authorizing a program of work on its Pitman property near Terrace, B.C. The Company has mobilized exploration crew to prepare its Golden Dragon and Dragon Tale prospect areas for drilling. The Pitman comprises both historic and recently discovered significant gold mineralization zones that Casa has explored in recent years. In addition to technical surveys, 2019 work will include prepa...
Aug 14, 2019 03:05 ET
New Destiny Mobilizes Drill to Treasure Mountain Project, Tulameen B.C.
VANCOUVER, BC / ACCESSWIRE / August 14, 2019 / New Destiny Mining Corp. (TSXV: NED), (the “Company” or “NED”) is pleased to announce that it is mobilizing a drill to its Treasure Mountain Silver property, located near Tulameen, B.C....
Aug 14, 2019 02:00 ET
Georgia Healthcare Group PLC Announces Half-Year Report
GEL million; unless otherwise noted...
Aug 14, 2019 01:25 ET
Evotec Se Reports First Half-Year 2019 Results And Corporate Updates
HAMBURG, GERMANY / ACCESSWIRE / August 14, 2019 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today reported financial results and corporate updates for the first half of 2019....
Aug 13, 2019 19:35 ET
Gamehost Announces Second Quarter 2019 Financial Results and August Dividend
Not Intended for Distribution to U.S. Newswire Services or for Dissemination in the U.S....
Aug 13, 2019 18:30 ET
Jackpot Enters into a New Debt Settlement Agreement with Everi
VANCOUVER, BC / ACCESSWIRE / August 13, 2019 / Jackpot Digital Inc. (the “Company” or “Jackpot”) (TSX-V:JP)(TSX-V:JP.WT)(OTCQB:JPOTF) (Frankfurt:LVH2). The Company is pleased to announce that effective as of 24 July, 2019, the Company has entered into a Debt Settlement Agreement (the “Agreement”) with Everi Games Inc. (“Everi”) whereby the Company and Everi have agreed that the Principal Amount of US $1,355,355.29 plus all accrued interest which was owed by the Company to Everi pursuant to previous Debt Settlement and Amendment Agreements have now been extingu...
Aug 13, 2019 17:30 ET
U. S. Antimony Announces Investor Call
Conference Title: United States Antimony Corp....
Aug 13, 2019 16:35 ET
Liberated Syndication To Host Second Quarter 2019 Shareholder Conference Call
PITTSBURGH, PA / ACCESSWIRE / August 13, 2019 / Liberated Syndication (OTCQB:LSYN) (“Libsyn”) announced today ...
Aug 13, 2019 16:30 ET
VistaGen Therapeutics Reports Fiscal 2020 First Quarter Financial Results
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / August 13, 2019 / VistaGen Therapeutics (NASDAQ:VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) diseases and disorders with high unmet need, today announced financial results for its fiscal year 2020 first quarter ended June 30, 2019....
Aug 13, 2019 16:15 ET
Dolphin Entertainment Q2 Revenue Increases 20% Year-Over-Year to $6.3 Million
Entertainment Publicity and Marketing revenue increases 23% year-over-year to a record $6.3 million...
Aug 13, 2019 16:15 ET
Oncolytics Biotech(R) Announces Public Offering of Common Shares and Warrants
Company ContactMichael MooreVice President, Investor Relations & Corporate Communications858-886-7813mmoore@oncolytics.ca ...
Aug 13, 2019 16:10 ET
Oncolytics Biotech(R) Reports 2019 Second Quarter Financial Results and Operational Highlights
Co-development agreement with Pfizer and Merck KGaA to evaluate Oncolytics' systemically delivered oncolytic virus, pelareorep, in combination with paclitaxel and anti-PD-L1 antibody avelumab ...